Related Experiment Video
Updated: Jul 26, 2025

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Cathepsin K inhibition induces Raptor destabilization and mitochondrial dysfunction via Syk/SHP2/Src/OTUB1
Seung Un Seo1, Seon Min Woo1, Taeg Kyu Kwon2,3
1Department of Immunology, School of Medicine, Keimyung University, Daegu, 42601, South Korea.
Abstract:
The Raptor signaling pathway is a critical point of intervention in the invasion and progression of cancer. The non-receptor tyrosine kinase Src-mediated phosphorylation of OTUB1-Y26 plays a critical role in Raptor stabilization, whereas cathepsin K inhibitor (odanacatib; ODN) and knockdown (siRNA) induce Raptor destabilization. However, the mechanisms involved in cathepsin K inhibition-induced OTUB1-Y26 phosphorylation in Raptor stabilization have not been yet elucidated. This study showed that cathepsin K inhibition activates SHP2, a tyrosine phosphatase, that dephosphorylates OTUB1 and destabilizes Raptor, whereas SHP2 deletion and pharmacological inhibition increase OTUB1-Y26 phosphorylation and Raptor expression. SHP2 deletion also led to the inhibition of ODN-induced mitochondrial ROS, fusion, and dysfunction. Furthermore, cathepsin K inhibition phosphorylated spleen tyrosine kinase (Syk) at Y525 and Y526, resulting in the SHP2-mediated dephosphorylation of OTUB1-Y26. Collectively, our findings identified Syk not only as an upstream tyrosine kinase required for SHP2 activation but also showed a critical mechanism that regulates ODN-induced Raptor downregulation and mitochondrial dysfunction. In conclusion, Syk/SHP2/Src/OTUB1 axis-mediated signaling can act as a therapeutic target in cancer management.
Insights
The study reveals how inhibiting cathepsin K impacts the Raptor pathway in cancer. It identifies a Syk/SHP2/Src/OTUB1 signaling axis that could be a therapeutic target for cancer management.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The Raptor signaling pathway is crucial in cancer progression.
- Src-mediated phosphorylation of OTUB1-Y26 stabilizes Raptor.
- Cathepsin K inhibition (odanacatib; ODN) destabilizes Raptor, but mechanisms are unclear.
Purpose of the Study:
- To elucidate the mechanisms of cathepsin K inhibition-induced OTUB1-Y26 phosphorylation and Raptor stabilization.
- To investigate the role of SHP2 and Syk in this pathway.
- To explore the impact on mitochondrial function.
Main Methods:
- Utilized SHP2 deletion and pharmacological inhibition.
- Investigated spleen tyrosine kinase (Syk) phosphorylation.
- Assessed mitochondrial reactive oxygen species (ROS), fusion, and dysfunction.
Main Results:
- Cathepsin K inhibition activates SHP2, dephosphorylating OTUB1 and destabilizing Raptor.
- SHP2 deletion increases OTUB1-Y26 phosphorylation and Raptor expression.
- Cathepsin K inhibition activates Syk, leading to SHP2-mediated OTUB1-Y26 dephosphorylation and mitochondrial dysfunction.
Conclusions:
- Syk is an upstream kinase activating SHP2, regulating ODN-induced Raptor downregulation and mitochondrial dysfunction.
- The Syk/SHP2/Src/OTUB1 signaling axis represents a potential therapeutic target in cancer.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
09:29Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
Published on: May 4, 2016
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
Destabilization of Microtubules
Amplifying Signals via Enzymatic Cascade